Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 132 entries
Sorted by: Best Match Show Resources per page
Robbery in progress: Historical museum collections bring to light a mitochondrial capture within a bird species widespread across southern Australia, the Copperback Quail-thrush .

Ecology and evolution

McElroy K, Black A, Dolman G, Horton P, Pedler L, Campbell CD, Drew A, Joseph L.
PMID: 32724551
Ecol Evol. 2020 May 31;10(13):6785-6793. doi: 10.1002/ece3.6403. eCollection 2020 Jul.

We surveyed mitochondrial, autosomal, and Z chromosome diversity within and between the Copperback Quail-thrush

Cite
McElroy K, Black A, Dolman G, et al. Robbery in progress: Historical museum collections bring to light a mitochondrial capture within a bird species widespread across southern Australia, the Copperback Quail-thrush . Ecol Evol. 2020;10(13):6785-6793doi: 10.1002/ece3.6403.
McElroy, K., Black, A., Dolman, G., Horton, P., Pedler, L., Campbell, C. D., Drew, A., & Joseph, L. (2020). Robbery in progress: Historical museum collections bring to light a mitochondrial capture within a bird species widespread across southern Australia, the Copperback Quail-thrush . Ecology and evolution, 10(13), 6785-6793. https://doi.org/10.1002/ece3.6403
McElroy, Kerensa, et al. "Robbery in progress: Historical museum collections bring to light a mitochondrial capture within a bird species widespread across southern Australia, the Copperback Quail-thrush ." Ecology and evolution vol. 10,13 (2020): 6785-6793. doi: https://doi.org/10.1002/ece3.6403
McElroy K, Black A, Dolman G, Horton P, Pedler L, Campbell CD, Drew A, Joseph L. Robbery in progress: Historical museum collections bring to light a mitochondrial capture within a bird species widespread across southern Australia, the Copperback Quail-thrush . Ecol Evol. 2020 May 31;10(13):6785-6793. doi: 10.1002/ece3.6403. eCollection 2020 Jul. PMID: 32724551; PMCID: PMC7381587.
Copy Download .nbib Format: NLM
Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

The American surgeon

Perry L, Radzevich J, Kelter D, Gott M, Slotman G, Kulkarni N, Gundlapalli V.
PMID: 32931319
Am Surg. 2020 Sep 15;3134820951422. doi: 10.1177/0003134820951422. Epub 2020 Sep 15.

No abstract available.

Cite
Perry L, Radzevich J, Kelter D, et al. Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Am Surg. 2020;3134820951422doi: 10.1177/0003134820951422.
Perry, L., Radzevich, J., Kelter, D., Gott, M., Slotman, G., Kulkarni, N., & Gundlapalli, V. (2020). Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). The American surgeon, 3134820951422. https://doi.org/10.1177/0003134820951422
Perry, Luke, et al. "Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)." The American surgeon vol. (2020): 3134820951422. doi: https://doi.org/10.1177/0003134820951422
Perry L, Radzevich J, Kelter D, Gott M, Slotman G, Kulkarni N, Gundlapalli V. Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Am Surg. 2020 Sep 15;3134820951422. doi: 10.1177/0003134820951422. Epub 2020 Sep 15. PMID: 32931319.
Copy Download .nbib Format: NLM
Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre.

Orphanet journal of rare diseases

Altman G, Hussain K, Green D, Strauss BJG, Wilcox G.
PMID: 34930395
Orphanet J Rare Dis. 2021 Dec 20;16(1):520. doi: 10.1186/s13023-021-02138-z.

BACKGROUND: Recently published European Society for Phenylketonuria (ESPKU) guidelines have recommended a lifelong diet with phenylalanine (Phe) control ≤ 600 μmol/L for phenylketonuria (PKU) patients. This study aimed to identify whether PKU adult patients are at a higher risk...

Cite
Altman G, Hussain K, Green D, et al. Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre. Orphanet J Rare Dis. 2021;16(1):520doi: 10.1186/s13023-021-02138-z.
Altman, G., Hussain, K., Green, D., Strauss, B. J. G., & Wilcox, G. (2021). Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre. Orphanet journal of rare diseases, 16(1), 520. https://doi.org/10.1186/s13023-021-02138-z
Altman, George, et al. "Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre." Orphanet journal of rare diseases vol. 16,1 (2021): 520. doi: https://doi.org/10.1186/s13023-021-02138-z
Altman G, Hussain K, Green D, Strauss BJG, Wilcox G. Mental health diagnoses in adults with phenylketonuria: a retrospective systematic audit in a large UK single centre. Orphanet J Rare Dis. 2021 Dec 20;16(1):520. doi: 10.1186/s13023-021-02138-z. PMID: 34930395.
Copy Download .nbib Format: NLM
Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs.

Molecular informatics

Saiakhov R, Chakravarti S, Klopman G.
PMID: 27481026
Mol Inform. 2013 Jan;32(1):87-97. doi: 10.1002/minf.201200081. Epub 2013 Jan 14.

Purpose of this pilot study is to test the QSAR expert system CASE Ultra for adverse effect prediction of drugs. 870 drugs from the SIDER adverse effect dataset were tested using CASE Ultra for carcinogenicity, genetic, liver, cardiac, renal...

Cite
Saiakhov R, Chakravarti S, Klopman G. Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs. Mol Inform. 2013;32(1):87-97doi: 10.1002/minf.201200081.
Saiakhov, R., Chakravarti, S., & Klopman, G. (2013). Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs. Molecular informatics, 32(1), 87-97. https://doi.org/10.1002/minf.201200081
Saiakhov, Roustem, et al. "Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs." Molecular informatics vol. 32,1 (2013): 87-97. doi: https://doi.org/10.1002/minf.201200081
Saiakhov R, Chakravarti S, Klopman G. Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs. Mol Inform. 2013 Jan;32(1):87-97. doi: 10.1002/minf.201200081. Epub 2013 Jan 14. PMID: 27481026.
Copy Download .nbib Format: NLM
Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer.

Contemporary clinical trials

Klotz L, Andriole G, Cash H, Cooperberg M, Crawford ED, Emberton M, Gomez-Sancha F, Klein E, Lughezzani G, Marks L, Montorsi F, Salomon G, Sanchez-Salas R, Shore N, Taneja S.
PMID: 34728381
Contemp Clin Trials. 2022 Jan;112:106618. doi: 10.1016/j.cct.2021.106618. Epub 2021 Nov 01.

BACKGROUND: Micro-ultrasound (microUS) is a novel ultrasound-based imaging modality which has demonstrated the ability to visualize prostate cancer. Multiparametric MRI/ultrasound (mpMRI/US) fusion has recognized advantages for the performance of prostate biopsy, however, it encompasses additional cost, time and technical...

Cite
Klotz L, Andriole G, Cash H, et al. Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 2021;112:106618doi: 10.1016/j.cct.2021.106618.
Klotz, L., Andriole, G., Cash, H., Cooperberg, M., Crawford, E. D., Emberton, M., Gomez-Sancha, F., Klein, E., Lughezzani, G., Marks, L., Montorsi, F., Salomon, G., Sanchez-Salas, R., Shore, N., & Taneja, S. (2022). Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. Contemporary clinical trials, 112106618. https://doi.org/10.1016/j.cct.2021.106618
Klotz, Laurence, et al. "Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer." Contemporary clinical trials vol. 112 (2022): 106618. doi: https://doi.org/10.1016/j.cct.2021.106618
Klotz L, Andriole G, Cash H, Cooperberg M, Crawford ED, Emberton M, Gomez-Sancha F, Klein E, Lughezzani G, Marks L, Montorsi F, Salomon G, Sanchez-Salas R, Shore N, Taneja S. Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer. Contemp Clin Trials. 2022 Jan;112:106618. doi: 10.1016/j.cct.2021.106618. Epub 2021 Nov 01. PMID: 34728381.
Copy Download .nbib Format: NLM
Effects of Demand Complexity on Echolalia in Students With Autism.

Behavior analysis in practice

Edelstein ML, Sloman K, Selver K.
PMID: 34868811
Behav Anal Pract. 2021 Feb 08;14(4):984-990. doi: 10.1007/s40617-020-00535-7. eCollection 2021 Dec.

Echolalia is a linguistic phenomenon common in individuals with autism spectrum disorder. We examined the relationship between demand complexity and immediate echolalia in four students with an autism diagnosis in a university-based academic setting. Mastered and novel antecedent verbal...

Cite
Edelstein ML, Sloman K, Selver K. Effects of Demand Complexity on Echolalia in Students With Autism. Behav Anal Pract. 2021;14(4):984-990doi: 10.1007/s40617-020-00535-7.
Edelstein, M. L., Sloman, K., & Selver, K. (2021). Effects of Demand Complexity on Echolalia in Students With Autism. Behavior analysis in practice, 14(4), 984-990. https://doi.org/10.1007/s40617-020-00535-7
Edelstein, Matthew L, et al. "Effects of Demand Complexity on Echolalia in Students With Autism." Behavior analysis in practice vol. 14,4 (2021): 984-990. doi: https://doi.org/10.1007/s40617-020-00535-7
Edelstein ML, Sloman K, Selver K. Effects of Demand Complexity on Echolalia in Students With Autism. Behav Anal Pract. 2021 Feb 08;14(4):984-990. doi: 10.1007/s40617-020-00535-7. eCollection 2021 Dec. PMID: 34868811; PMCID: PMC8586315.
Copy Download .nbib Format: NLM
[New renal physiological concept. Nephrorenal short circuit and intertubular or nephronal space].

Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana

ALOMAR G.
PMID: 13682647
Bol Cult Inf Cons Gen Col Med Esp. 1960 May;23:37-40.

No abstract available.

Cite
ALOMAR G. [New renal physiological concept. Nephrorenal short circuit and intertubular or nephronal space]. Bol Cult Inf Cons Gen Col Med Esp. 1960;23:37-40
ALOMAR, G. (1960). [New renal physiological concept. Nephrorenal short circuit and intertubular or nephronal space]. Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana, 2337-40.
ALOMAR, G. "[New renal physiological concept. Nephrorenal short circuit and intertubular or nephronal space]." Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana vol. 23 (1960): 37-40.
ALOMAR G. [New renal physiological concept. Nephrorenal short circuit and intertubular or nephronal space]. Bol Cult Inf Cons Gen Col Med Esp. 1960 May;23:37-40. Spanish. PMID: 13682647.
Copy Download .nbib Format: NLM
[Cytological diagnosis of cancer].

Revista brasileira de cirurgia

BASTOS W, VILLACA J, TEIXEIRA C, FALCI A, DE LACERDA L, NETTO JM, COELHO F, VILLACA L, CAMPOS W, SALOMAO G, LIMA C, VILLELA C, TORRES P.
PMID: 14372247
Rev Bras Cir. 1954 Nov;28(5):363-82.

No abstract available.

Cite
BASTOS W, VILLACA J, TEIXEIRA C, et al. Diagnóstico citológico do câncer. [Cytological diagnosis of cancer]. Rev Bras Cir. 1954;28(5):363-82
BASTOS, W., VILLACA, J., TEIXEIRA, C., FALCI, A., DE LACERDA, L., NETTO, J. M., COELHO, F., VILLACA, L., CAMPOS, W., SALOMAO, G., LIMA, C., VILLELA, C., & TORRES, P. (1954). Diagnóstico citológico do câncer. [Cytological diagnosis of cancer]. Revista brasileira de cirurgia, 28(5), 363-82.
BASTOS, W, et al. "Diagnóstico citológico do câncer." [Cytological diagnosis of cancer]. Revista brasileira de cirurgia vol. 28,5 (1954): 363-82.
BASTOS W, VILLACA J, TEIXEIRA C, FALCI A, DE LACERDA L, NETTO JM, COELHO F, VILLACA L, CAMPOS W, SALOMAO G, LIMA C, VILLELA C, TORRES P. Diagnóstico citológico do câncer. [Cytological diagnosis of cancer]. Rev Bras Cir. 1954 Nov;28(5):363-82. Portuguese. PMID: 14372247.
Copy Download .nbib Format: NLM
An unusual infection in an immunocompetent male from a non-endemic area: Lessons from a vacation.

Clinics and practice

Neupane R, Sharma M, Sharma D, Thachil R, Krishnamurthy M, Lowman G.
PMID: 31579493
Clin Pract. 2019 Aug 09;9(3):1141. doi: 10.4081/cp.2019.1141. eCollection 2019 Aug 02.

Primary pulmonary histoplasmosis is found worldwide, and is particularly endemic in some areas of North America, usually those surrounding the Ohio and Mississippi river valleys. It is not common in the East Coast of the United States, and is...

Cite
Neupane R, Sharma M, Sharma D, et al. An unusual infection in an immunocompetent male from a non-endemic area: Lessons from a vacation. Clin Pract. 2019;9(3):1141doi: 10.4081/cp.2019.1141.
Neupane, R., Sharma, M., Sharma, D., Thachil, R., Krishnamurthy, M., & Lowman, G. (2019). An unusual infection in an immunocompetent male from a non-endemic area: Lessons from a vacation. Clinics and practice, 9(3), 1141. https://doi.org/10.4081/cp.2019.1141
Neupane, Ritesh, et al. "An unusual infection in an immunocompetent male from a non-endemic area: Lessons from a vacation." Clinics and practice vol. 9,3 (2019): 1141. doi: https://doi.org/10.4081/cp.2019.1141
Neupane R, Sharma M, Sharma D, Thachil R, Krishnamurthy M, Lowman G. An unusual infection in an immunocompetent male from a non-endemic area: Lessons from a vacation. Clin Pract. 2019 Aug 09;9(3):1141. doi: 10.4081/cp.2019.1141. eCollection 2019 Aug 02. PMID: 31579493; PMCID: PMC6755260.
Copy Download .nbib Format: NLM
Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64].

European urology

Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S.
PMID: 28065298
Eur Urol. 2010 Oct;58(4):644. doi: 10.1016/j.eururo.2010.07.001. Epub 2010 Jul 09.

No abstract available.

Cite
Eggener S, Salomon G, Scardino PT, et al. Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64]. Eur Urol. 2010;58(4):644doi: 10.1016/j.eururo.2010.07.001.
Eggener, S., Salomon, G., Scardino, P. T., De la Rosette, J., Polascik, T. J., & Brewster, S. (2010). Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64]. European urology, 58(4), 644. https://doi.org/10.1016/j.eururo.2010.07.001
Eggener, Scott, et al. "Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64]." European urology vol. 58,4 (2010): 644. doi: https://doi.org/10.1016/j.eururo.2010.07.001
Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S. Corrigendum to "Focal Therapy for Prostate Cancer: Possibilities and Limitations" [Eur Urol 2010;58:57-64]. Eur Urol. 2010 Oct;58(4):644. doi: 10.1016/j.eururo.2010.07.001. Epub 2010 Jul 09. PMID: 28065298.
Copy Download .nbib Format: NLM
A new MR-SAD algorithm for the automatic building of protein models from low-resolution X-ray data and a poor starting model.

IUCrJ

Skubák P, Araç D, Bowler MW, Correia AR, Hoelz A, Larsen S, Leonard GA, McCarthy AA, McSweeney S, Mueller-Dieckmann C, Otten H, Salzman G, Pannu NS.
PMID: 29765606
IUCrJ. 2018 Jan 25;5:166-171. doi: 10.1107/S2052252517017961. eCollection 2018 Mar 01.

Determining macromolecular structures from X-ray data with resolution worse than 3 Å remains a challenge. Even if a related starting model is available, its incompleteness or its bias together with a low observation-to-parameter ratio can render the process unsuccessful...

Cite
Skubák P, Araç D, Bowler MW, et al. A new MR-SAD algorithm for the automatic building of protein models from low-resolution X-ray data and a poor starting model. IUCrJ. 2018;5:166-171doi: 10.1107/S2052252517017961.
Skubák, P., Araç, D., Bowler, M. W., Correia, A. R., Hoelz, A., Larsen, S., Leonard, G. A., McCarthy, A. A., McSweeney, S., Mueller-Dieckmann, C., Otten, H., Salzman, G., & Pannu, N. S. (2018). A new MR-SAD algorithm for the automatic building of protein models from low-resolution X-ray data and a poor starting model. IUCrJ, 5166-171. https://doi.org/10.1107/S2052252517017961
Skubák, Pavol, et al. "A new MR-SAD algorithm for the automatic building of protein models from low-resolution X-ray data and a poor starting model." IUCrJ vol. 5 (2018): 166-171. doi: https://doi.org/10.1107/S2052252517017961
Skubák P, Araç D, Bowler MW, Correia AR, Hoelz A, Larsen S, Leonard GA, McCarthy AA, McSweeney S, Mueller-Dieckmann C, Otten H, Salzman G, Pannu NS. A new MR-SAD algorithm for the automatic building of protein models from low-resolution X-ray data and a poor starting model. IUCrJ. 2018 Jan 25;5:166-171. doi: 10.1107/S2052252517017961. eCollection 2018 Mar 01. PMID: 29765606; PMCID: PMC5947721.
Copy Download .nbib Format: NLM
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.

Oncotarget

Kluth M, Ahrary R, Hube-Magg C, Ahmed M, Volta H, Schwemin C, Steurer S, Wittmer C, Wilczak W, Burandt E, Krech T, Adam M, Michl U, Heinzer H, Salomon G, Graefen M, Koop C, Minner S, Simon R, Sauter G, Schlomm T.
PMID: 28143998
Oncotarget. 2017 Jan 10;8(2):3761. doi: 10.18632/oncotarget.14557.

No abstract available.

Cite
Kluth M, Ahrary R, Hube-Magg C, et al. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer. Oncotarget. 2017;8(2):3761doi: 10.18632/oncotarget.14557.
Kluth, M., Ahrary, R., Hube-Magg, C., Ahmed, M., Volta, H., Schwemin, C., Steurer, S., Wittmer, C., Wilczak, W., Burandt, E., Krech, T., Adam, M., Michl, U., Heinzer, H., Salomon, G., Graefen, M., Koop, C., Minner, S., Simon, R., Sauter, G., & Schlomm, T. (2017). Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer. Oncotarget, 8(2), 3761. https://doi.org/10.18632/oncotarget.14557
Kluth, Martina, et al. "Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer." Oncotarget vol. 8,2 (2017): 3761. doi: https://doi.org/10.18632/oncotarget.14557
Kluth M, Ahrary R, Hube-Magg C, Ahmed M, Volta H, Schwemin C, Steurer S, Wittmer C, Wilczak W, Burandt E, Krech T, Adam M, Michl U, Heinzer H, Salomon G, Graefen M, Koop C, Minner S, Simon R, Sauter G, Schlomm T. Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer. Oncotarget. 2017 Jan 10;8(2):3761. doi: 10.18632/oncotarget.14557. PMID: 28143998; PMCID: PMC5356916.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 132 entries